Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Centessa Pharmaceuticals (CNTA) Non Operating Income: 2019-2024

Historic Non Operating Income for Centessa Pharmaceuticals (CNTA) over the last 6 years, with Dec 2024 value amounting to -$1.7 million.

  • Centessa Pharmaceuticals' Non Operating Income fell 149.40% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year decrease of 182.68%. This contributed to the annual value of -$1.7 million for FY2024, which is 68.92% up from last year.
  • As of FY2024, Centessa Pharmaceuticals' Non Operating Income stood at -$1.7 million, which was up 68.92% from -$5.4 million recorded in FY2023.
  • In the past 5 years, Centessa Pharmaceuticals' Non Operating Income registered a high of $2.3 million during FY2022, and its lowest value of -$5.4 million during FY2023.
  • Over the past 3 years, Centessa Pharmaceuticals' median Non Operating Income value was -$1.7 million (recorded in 2024), while the average stood at -$1.6 million.
  • In the last 5 years, Centessa Pharmaceuticals' Non Operating Income plummeted by 2,919.35% in 2021 and then skyrocketed by 153.59% in 2022.
  • Over the past 5 years, Centessa Pharmaceuticals' Non Operating Income (Yearly) stood at $155,000 in 2020, then plummeted by 2,919.35% to -$4.4 million in 2021, then surged by 153.59% to $2.3 million in 2022, then slumped by 331.77% to -$5.4 million in 2023, then surged by 68.92% to -$1.7 million in 2024.